Trial intelligence / Profile preview

Vitamin D Nasal Drops for Post COVID-19 Parosmia

NCT05269017Phase 2Unknown

Sponsor
Menoufia University
Start
Jun 2022
Primary completion
Mar 2023
Modality
Transdermal Patches, Orthosteric Ligands, Hydrogel Systems
Countries
1
01

Overview

Phase 2, randomised, open-label trial of cholecalciferol cream in parosmia (2 arms), sponsored by Menoufia University. Primary endpoints: Visual Analog Scale of Parosmia at 1 month and Post-treatment Improvement Categories at 1 month. Status: unknown.

02

Drugs

cholecalciferol cream
03

Conditions

parosmia

Beyond the preview

Go deeper on NCT05269017.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05269017.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call